Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gout Flares”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Large-scale testing (Phase 3)Study completedNCT00958438
What this trial is testing

PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations (PRE-SURGE 2)

Who this might be right for
Gout
Regeneron Pharmaceuticals 248
Testing effectiveness (Phase 2)UnknownNCT06270225
What this trial is testing

SSGJ-613 in Gout Subjects Initiating Urate-Lowering Treatment.

Who this might be right for
Gout Arthritis
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 157
Large-scale testing (Phase 3)Ended earlyNCT01459796
What this trial is testing

Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares

Who this might be right for
Gout
Regeneron Pharmaceuticals 220
Testing effectiveness (Phase 2)Study completedNCT00927810
What this trial is testing

Long Term Study of Canakinumab (ACZ885) in Patients With Gout

Who this might be right for
Gouty Arthritis
Novartis Pharmaceuticals 341
Testing effectiveness (Phase 2)Study completedNCT02063997
What this trial is testing

Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients

Who this might be right for
Gout
Gilead Sciences 248
Testing effectiveness (Phase 2)Study completedNCT05936281
What this trial is testing

The Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202)

Who this might be right for
GoutGout Initiating Urate-loweringUrate-lowering Therapy
Changchun GeneScience Pharmaceutical Co., Ltd. 165
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07708181
What this trial is testing

SSGJ-613 in Gout Participants Initiating Urate-Lowering Treatment

Who this might be right for
Gout Arthritis
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 200
Not applicableStudy completedNCT01568879
What this trial is testing

Evaluating the Effectiveness of a Chronic Disease Management Program for Gout

Who this might be right for
Recurrent or Tophaceous Gout
Kaiser Permanente 104
Not applicableNot Yet RecruitingNCT07616531
What this trial is testing

Efficacy and Safety of Scheduled Versus As-Needed Firsekibart Administration for the Prevention of Gout Recurrence: A Multicenter, Open-Label, Randomized Controlled Trial

Who this might be right for
Gout Flares
Second Affiliated Hospital, Zhejiang University, School of Medicine 118
Large-scale testing (Phase 3)Ended earlyNCT01362608
What this trial is testing

Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective

Who this might be right for
Gouty Arthritis
Novartis Pharmaceuticals 136
Not applicableUnknownNCT04069325
What this trial is testing

Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat Therapy

Who this might be right for
Gout Flare
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 72
Testing effectiveness (Phase 2)Study completedNCT00798369
What this trial is testing

Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients

Who this might be right for
Acute Gout
Novartis 200
Large-scale testing (Phase 3)Study completedNCT01029652
What this trial is testing

Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine Including a 12 Weeks Extension and an Open-label 48 Weeks Extension Study

Who this might be right for
Acute Gout
Novartis Pharmaceuticals 230
Testing effectiveness (Phase 2)Study completedNCT01712204
What this trial is testing

A Proof-of-Concept Study of AC-201 to Prevent Gout Flares

Who this might be right for
Gout Flares
TWi Biotechnology, Inc. 82
Large-scale testing (Phase 3)Study completedNCT05983445
What this trial is testing

Safety & Efffficacy of Genakumab in Patients With Frequent Flares

Who this might be right for
Acute Gout Arthritis
Changchun GeneScience Pharmaceutical Co., Ltd. 313
Large-scale testing (Phase 3)Study completedNCT00829829
What this trial is testing

PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1

Who this might be right for
Intercritical Gout
Regeneron Pharmaceuticals 241
Not applicableUnknownNCT05744297
What this trial is testing

NLRP3 Inflammasome Activation Among Patients During Acute Gout Flares

Who this might be right for
Gout Arthritis
Centre Hospitalier Saint Joseph Saint Luc de Lyon 10
Post-approval studies (Phase 4)Study completedNCT00170781
What this trial is testing

Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout

Who this might be right for
Acute Gouty Arthritis
Novartis 234
Post-approval studies (Phase 4)Looking for participantsNCT07346079
What this trial is testing

Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares

Who this might be right for
Gout ArthritisGout FlareGout
Massachusetts General Hospital 150
Not applicableStudy completedNCT02855437
What this trial is testing

Novel Methods for Ascertainment of Gout Flares -A Pilot Study

Who this might be right for
Gout
University of Alabama at Birmingham 44
Next Page